Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Dr.Reddy's Laboratories Ltd    DRREDDY   INE089A01023

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
2197(c) 2255(c) 2264(c) 2313.75(c) 2370 Last
377 793 1 482 214 401 576 836 204 743 680 Volume
+0.48% +2.64% +0.40% +2.20% +2.43% Change
More quotes
Financials ( INR)
Sales 2018 147 B
EBIT 2018 16 369 M
Net income 2018 12 872 M
Debt 2018 31 109 M
Yield 2018 0,80%
Sales 2019 169 B
EBIT 2019 26 338 M
Net income 2019 20 563 M
Debt 2019 24 172 M
Yield 2019 0,98%
P/E ratio 2018 29,39
P/E ratio 2019 18,32
EV / Sales2018 2,82x
EV / Sales2019 2,40x
Capitalization 383 B
More Financials
Company
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products.It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others.The Global Generics segment is consist of... 
Sector
Pharmaceuticals
Calendar
02/02Earnings Release
More about the company
Surperformance© ratings of Dr.Reddy's Laboratories Lt
Trading Rating : Investor Rating :
More Ratings
Latest news on DR.REDDY'S LABORATORIES LT
12/14 DR REDDY LABORATORIES : Reddys Laboratories receives EIR for its facility at Bac..
12/13 DR REDDY LABORATORIES : . Reddy's gets USFDA nod for melphalan hyochloride
12/04 DR REDDY LABORATORIES : . Reddy's Announces Approval of Impoyz Cream, 0.025% Fir..
12/02 DR REDDY LABORATORIES : Reddys gets nod to restart exports to EU from Visakhapat..
12/02 DR REDDY LABORATORIES : .Reddy`s gets USFDA nod for Impoyz cream
12/01 DR REDDY LABORATORIES : Arm gets fda nod for drug
12/01 DR REDDY LABORATORIES : .Reddy's Miyapur unit gets USFDA EIR report
12/01 Indian ADRs end mixed; Tata Motors, ICICI Bank fall
12/01 DR REDDY LABORATORIES : . Reddy’s Announces Approval of Impoyz™ (clo..
11/30 DR REDDY LABORATORIES : Gets nod to restart exports to eu from vizag plant
More news
Sector news : Pharmaceuticals - NEC
02:48aDJTEVA PHARMACEUTICAL INDUSTRIES : Generics Giant Cuts Staff by 25% -- WSJ
01:34aDJNOVARTIS : Oncology CEO Bruno Strigini to Retire
12/14 Wall Street falls as investors fret about tax bill passage
12/14 TSX in broad retreat led by Cenovus, other energy stocks
12/14 Perrigo lines up bid for Merck's consumer health unit - sources
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/01 Dr. Reddy?s announces approval of Impoyz cream, 0.025% first-cycle NDA
11/29 HOLD ON TO NEKTAR THERAPEUTICS : There Is Much More Ammunition Left In Its Partn..
11/21 FDA issues guidance on development of generic abuse-deterrent opioids
11/21 Celgene up 2% after would-be generic competitor misses deadline to file for R..
11/14 Dr. Reddy's launches generic Clolar in U.S.
Chart DR.REDDY'S LABORATORIES LT
Duration : Period :
Dr.Reddy's Laboratories Lt Technical Analysis Chart | DRREDDY | INE089A01023 | 4-Traders
Technical analysis trends DR.REDDY'S LABORATORIES LT
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 42
Average target price 2 572  INR
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Gunupati Venkateswara Prasad Co-Chairman, Chief Executive Officer & MD
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Abhijit Mukherjee Chief Operating Officer
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR.REDDY'S LABORATORIES LTD-28.45%5 978
JOHNSON & JOHNSON21.53%383 877
NOVARTIS12.01%221 304
PFIZER10.04%218 400
ROCHE HOLDING LTD.3.40%210 833
MERCK AND COMPANY-6.96%155 214